322 professor-computer "https:" "https:" "https:" "https:" "https:" "Dr" "St" "St" Postdoctoral positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
biophysical techniques such as NMR spectroscopy and/or small-angle X-ray scattering is required to capitalize on the opportunities of this project. About the lab and St. Jude: The successful candidate will join
-
photonics, nonlinear optics, and frequency metrology is highly desirable. Specific skills of interest include design of integrated photonics devices using commercial computational electromagnetic modeling
-
an experience in technology-assisted monitoring or computational image analysis. Expected start date and duration of employment The position will start in June 2026, with exact starting date as agreed between
-
The Microbiome Dynamics (MBD) department contributes, using computational methods, to the development of personalized microbiome-based strategies to aid in the detection, monitoring, treatment, and prevention
-
and clathrin (PMID: 29921601 and BioRxiv https://doi.org/10.1101/2025.08.20.671218). Septins act as a restriction factor that suppresses viral release from the cell, while clathrin enhances viral spread
-
The Translational Cancer Immunogenomics (TCI) Research Group, led by Dr. Ángel Álvarez-Prado at the Department of Cancer Research of LIH, is currently offering a postdoctoral researcher position
-
dates, but successful applicants are welcome to take up post in New Haven starting July 1, 2026. Application & Selection Process Please apply online at https://career.bmedx.com/registration/2025-NHV-C01
-
university. The postdoctoral researcher will work with Professor Dr Janne Fengler on gaining understandings of contexts and processes of learning and teaching. The ideal candidate has substantive interest in
-
in nanotechnology may also be considered. The Zhang laboratory functions as an integrated translational research program with the goal of designing and developing new immunotherapies and immunologic
-
Disease. The antibodies will be engineered for optimal target engagement. The work involves a close collaboration with PI Dr. Simon Glerup (CSO, Draupnir Bio ApS) and Assoc. Prof. Nathalie Van Den Berge